LGR5 and neoplasm: A recent study using an inducible lineage-tracing system in CRC organoid xenografts has revealed that dormant LGR5+p27+ cells, anchored at the COL17A1-enriched matrix interface, persist in a drug-tolerant state during chemotherapy and later reinitiate tumor growth [25].